133 related articles for article (PubMed ID: 10616508)
1. CD28 regulation in liver transplant recipients treated with two different immunosuppressive regimens.
Charco R; Caragol I; Urbán S; Lázaro JL; Murio E; Dávila R; Margarit C
Transplant Proc; 1999 Dec; 31(8):3365-6. PubMed ID: 10616508
[No Abstract] [Full Text] [Related]
2. [Regulatory function of tacrolimus and CsA on CD4/CD8 T lymphocyte subgroups and costimulators on them in allo-liver recipients].
Bai YJ; Wang LL; Cai B; Zou YG; Feng WH; Yan LN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):989-92. PubMed ID: 18845086
[TBL] [Abstract][Full Text] [Related]
3. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
[No Abstract] [Full Text] [Related]
4. Early steroid withdrawal after liver transplantation.
Ramirez CB; Sebayel MI; Kizilisik T
Transplant Proc; 1998 Nov; 30(7):3182-3. PubMed ID: 9838406
[No Abstract] [Full Text] [Related]
5. Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation.
Alberti D; Reding R; Otte JB; Falchetti D; Rigamonti W; Caccia G; Sokal E; de Ville de Goyet J
Transplant Proc; 1998 Aug; 30(5):1858-60. PubMed ID: 9723310
[No Abstract] [Full Text] [Related]
6. Tolerability of mycophenolate mofetil in organ transplant recipients.
Schweizer RT; Meisterling LD
Transplant Proc; 2001 May; 33(3):2309. PubMed ID: 11377540
[No Abstract] [Full Text] [Related]
7. Distribution of lymphocyte subtypes in liver transplant recipients.
Rayes N; Bechstein WO; Volk HP; Tullius SG; Nüssler N; Naumann U; Jonas S; Neuhaus R; Serke S; Neuhaus P
Transplant Proc; 1997; 29(1-2):501-2. PubMed ID: 9123103
[No Abstract] [Full Text] [Related]
8. Homeostatic repopulation by CD28-CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression.
Trzonkowski P; Zilvetti M; Chapman S; Wieckiewicz J; Sutherland A; Friend P; Wood KJ
Am J Transplant; 2008 Feb; 8(2):338-47. PubMed ID: 18211507
[TBL] [Abstract][Full Text] [Related]
9. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
Reggiani P; Rossi G; Latham L; Caccamo L; Gatti S; Maggi U; Melada E; Paone G; Doglia M; Vannelli A; Fassati LR
Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
[No Abstract] [Full Text] [Related]
10. Experience with neoral cyclosporine through the oral route in liver transplantation.
Bilbao I; Lazaro JL; Pou L; Charco R; Hildalgo E; Murio E; Margarit C
Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580
[No Abstract] [Full Text] [Related]
11. Corticosteroid-free therapy after tacrolimus-based dual immunosuppression versus cyclosporine-based quadruple-induction therapy.
Jonas S; Guckelberger O; Tullius SG; Steinmüller T; Müller AR; Grauhan O; Langrehr JM; Bechstein WO; Neuhaus P
Transplant Proc; 2001 May; 33(3):2232-3. PubMed ID: 11377511
[No Abstract] [Full Text] [Related]
12. Distribution of lymphocyte subtypes in liver transplant recipients with viral reinfection or de novo malignancy.
Rayes N; Bechstein WO; Tullius SG; Nüssler NC; Naumann U; Jonas S; Neuhaus R; Serke S; Neuhaus P
Transplant Proc; 1998 Aug; 30(5):1846-7. PubMed ID: 9723303
[No Abstract] [Full Text] [Related]
13. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study.
Mühlbacher F;
Transplant Proc; 2001; 33(1-2):1339-40. PubMed ID: 11267317
[No Abstract] [Full Text] [Related]
14. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
Bilbao I; Pou L; Allende E; Lázaro JL; Charco R; Hidalgo E; Margarit C
Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
[No Abstract] [Full Text] [Related]
15. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal.
Pons JA; Revilla-Nuin B; Baroja-Mazo A; Ramírez P; Martínez-Alarcón L; Sánchez-Bueno F; Robles R; Rios A; Aparicio P; Parrilla P
Transplantation; 2008 Nov; 86(10):1370-8. PubMed ID: 19034005
[TBL] [Abstract][Full Text] [Related]
16. Airway cellular response to two different immunosuppressive regimens in lung transplant recipients.
Slebos DJ; Kauffman HF; Koëter GH; Verschuuren EA; Bij W; Postma DS
Clin Transplant; 2005 Apr; 19(2):243-9. PubMed ID: 15740562
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous blockade of B7-CD28 and CD40-CD40L costimulation eliminates the direct xenorestricted human anti-porcine T-cell response.
Popma SH; Krasinskas AM; Kreisel D; Szeto W; McLean AD; Moore JS; Rosengard BR
Transplant Proc; 2001; 33(1-2):767-9. PubMed ID: 11267061
[No Abstract] [Full Text] [Related]
18. Cooperation between 4-1BB and ICOS in the immune response to influenza virus revealed by studies of CD28/ICOS-deficient mice.
Vidric M; Suh WK; Dianzani U; Mak TW; Watts TH
J Immunol; 2005 Dec; 175(11):7288-96. PubMed ID: 16301634
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of Neoral versus Sandimmune maintenance therapy for de novo liver transplant patients: results from an International Randomized Controlled Trial. Milton Study Group.
Peeters P; Kazek M; Abella I; Noble I
Transplant Proc; 1998 Aug; 30(5):1838-42. PubMed ID: 9723301
[No Abstract] [Full Text] [Related]
20. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.
Vingerhoets JH; Vanham GL; Kestens LL; Penne GG; Colebunders RL; Vandenbruaene MJ; Goeman J; Gigase PL; De Boer M; Ceuppens JL
Clin Exp Immunol; 1995 Jun; 100(3):425-33. PubMed ID: 7539725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
